Type 1 Diabetes Fellows Series

December 11, 2025

The 13th Annual Endocrine Fellows Conference: Type 1 Diabetes Care and Management provides advanced support to endocrine fellows as they begin their careers as practicing clinicians and diabetes experts. The in-person and online resources include engaging and comprehensive education as well as career development opportunities for building knowledge, practical skills, and a lasting network of colleagues.

The application deadline is January 31, 2026.

Have questions? Please contact [email protected] for assistance. 

As in years past, the Type 1 Diabetes Fellows Program will have three core components:  

  • On-demand didactic sessions;
  • A prestigious, in-person meeting held in Chicago, Illinois, June 11-12, 2026, ahead of ENDO, where fellows get the exclusive opportunity to meet with experts in T1D and product demonstrations with industry representatives;
  • A 30-minute podcast describing the latest standards in T1D management and lessons learned.

Learning Objectives

Upon successful completion of these educational initiatives, participants should be better able to: 

  • Discuss the prevalence and progression of type 1 diabetes to recognize signs and support early diagnosis.  
  • Discuss prevalence of type 1 diabetes at each stage, and also prevalence of overweight or obesity in this population.
  • Devise individualized treatment strategies that use new and emerging insulin and non-insulin therapies to manage individuals with type 1 diabetes with and without common comorbid conditions.
  • Incorporate diabetes technologies, including insulin pump therapy and continuous glucose monitoring, into treatment strategies for appropriate individuals with type 1 diabetes and evaluate data from those technologies.
  • Recognize and evaluate individuals with type 1 diabetes for signs of depression and distress using updated guidelines and practice tools.
  • Apply updated knowledge of treatments, practice guidelines, and clinical skills to improve care, long-term outcomes, exercise prescription, and sick day and hypoglycemia management of individuals with type 1 diabetes.
  • Describe current and emerging therapy for the treatment of pre-clinical type 1 diabetes.  

T1D Fellows 2026 Agenda 

The in-person program will take place at ENDO 2026 in the McCormick Place West Center, Chicago, IL. (All times are Central Time) (Subject to change)

Thursday, June 11, 2026

5:00 – 6:00 PM Check in and Networking Reception 
6:00 – 7:00 PM Device Demos
7:00 – 8:00 PM Dinner 
8:00 – 8:45 PM   
Keynote Address
8:45 – 9:00 PM            Q&A

Friday, June 12, 2026

7:00 – 8:00 AM  Registration and Breakfast with the Faculty 
8:00 – 8:15 AM  Welcoming Remarks from Program Chairs
8:15 – 9:00 AM  Diabetes Technology 
Session #1: CGM with Closed Loop

9:00 – 9:45 AM  Diabetes Technology
Session #2: Updates on Insulin Treatment 

9:45 – 10:30 AM  Diabetes Technology
Session #3: Diabetes in Pregnancy
 
10:30 – 11:00 AM  Break & Questions for Industry Representatives 
11:00 AM – 12:00 PM  Small Group Discussions - AM Session
12:00 – 1:00 PM  Lunch with Faculty 
1:00 PM – 1:45 PM  Session #4: Adjunctive Therapies
1:45 – 2:30 PM  Session #5: Immunotherapies for Type 1 Diabetes
2:30– 3:00 PM   Break & Questions for Industry Representatives 
3:00 – 4:00 PM  Small Group Discussions - PM Session
4:00 – 4:30 PM  Closing Comments
 

On-Demand Program

  • Diabetes and Pregnancy
  • T1D in Underserved Populations
  • Challenging Transitions (also discussion group)
  • The Pathogenesis of T1D/Stages of Diabetes
  • Newly Diagnosed T1D
  • Endo's role in screening and managing microvascular disease
  • Developmental Considerations for Youth with T1D and their Families
  • Psychosocial Care
  • T1D and Obesity
  • Applying New Billing
  • Hypoglycemia in T1D
  • T1D and Prevention/Treatment of Macrovascular Disease
  • Adjunctive Therapies
  • CGM Use and Interpretation with MDI
  • In-Patient Management
  • Realistic Nutrition Therapies 

Access 2025 lectures in our Center for Learning.

Visa Information 

All individuals traveling from outside the United States must apply for entry visas as soon as possible and at least four months prior to the date of travel for ENDO 2026. The most updated information may be found at the US State Department site. Scientists visiting the U.S. may find helpful information at The National Academies of Sciences website. Visa appointment wait times can be found here.

Please do not wait until ENDO 2026 registration opens in February 2026 before applying for a visa. All visitors traveling to the U.S. from visa waiver countries (i.e., Europe, Japan, Australia, etc.) must meet all requirements. If you need more information on the Electronic System for Travel Authorization (ESTA) or a list of visa waiver countries, click here.

To request a visa invitation letter or learn more, visit the Visa Information page.

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.